Summit Therapeutics Inc. (SMMT) › Operating Cash FlowSummit Therapeutics Inc. (SMMT) — Operating Cash FlowAnnual figures by period end, from SEC filings.2019-01-31: -$35.11M2020-12-31: -$48.11M2021-12-31: -$72.59M2022-12-31: -$41.58M2023-12-31: -$76.76M2024-12-31: -$142.11M2025-12-31: -$322.93M-$322.93M2019-01-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31-$322.93M—2026-02-23From 2025-01-012024-12-31-$142.11M—2026-02-23From 2024-01-012023-12-31-$76.76M—2026-02-23From 2023-01-012022-12-31-$41.58M—2025-02-24From 2022-01-012021-12-31-$72.59M—2023-03-09From 2021-01-012020-12-31-$48.11M—2022-12-21From 2020-01-012019-01-31-$35.11M—2021-03-31From 2018-02-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)